Analysis of minocycline as a countermeasure against acute radiation syndrome

In Vivo

Volumn 26, Issue 5, 2012, Pages 743-758

  Mehrotra, Shalini ^a   Pecaut, Michael J ^a   Gridley, Daila S ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Hematopoiesis; Ionizing radiation; Lymphocytes; Minocycline

Indexed keywords

CD3 ANTIBODY; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; MINOCYCLINE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE RADIATION SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; GRANULOCYTE; HEMATOPOIESIS; MACROPHAGE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; SPLEEN CELL;

EID: 84866610287     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Dainiak N, Waselenko JK, Armitage JO, MacVittie TJ and Farese AM: The hematologist and radiation casualties. Hematology Am Soc Hematol Educ Program: pp. 473-496, 2003.
2. Simonsen LC, Cucinotta FA, Atwell W and Nealy JE: Temporal analysis of the October 1989 proton flare using computerized anatomical models. Radiat Res 133(1): 1-11, 1993.
3. Singh VK, Singh PK, Wise SY and Seed TM: Mobilized progenitor cells as a bridging therapy for radiation casualties: a brief review of tocopherol succinate-based approaches. Int Immunopharmacol 11(7): 842-847, 2011.
4. Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, Tsu H, Confer DL, Coleman CN, Seed T, Lowry P, Armitage JO and Dainiak N: Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med 140(12): 1037-1051, 2004.
5. Kim K, Pollard JM, Norris AJ, McDonald JT, Sun Y, Micewicz E, Pettijohn K, Damoiseaux R, Iwamoto KS, Sayre JW, Price BD, Gatti RA and McBride WH: High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones. Clin Cancer Res 15(23): 7238-7245, 2009.
6. Heslet L, Bay C and Nepper-Christensen S: Acute radiation syndrome (ARS) - treatment of the reduced host defense. Int J Gen Med 5: 105-115, 2012.
7. Vriesendorp HM, Chu H, Ochran TG, Besa PC and Champlin RE: Radiobiology of total body radiation. Bone Marrow Transplant 14(Suppl 4): S4-8, 1994.
8. Stirling DP, Koochesfahani KM, Steeves JD and Tetzlaff W: Minocycline as a neuroprotective agent. Neuroscientist 11(4): 308-322, 2005. (Pubitemid 41040860)
9. Tikka T, Usenius T, Tenhunen M, Keinanen R and Koistinaho J: Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation. J Neurochem 78(6): 1409-1414, 2001. (Pubitemid 32899772)
10. Kraus RL, Pasieczny R, Lariosa-Willingham K, Turner MS, Jiang A and Trauger JW: Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem 94(3): 819-827, 2005. (Pubitemid 41098513)
11. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH and Koistinaho J: A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96(23): 13496-13500, 1999.
12. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T and Koistinaho J: Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95(26): 15769-15774, 1998. (Pubitemid 29018775)
13. Zhang C, Lei B, Lam TT, Yang F, Sinha D and Tso MO: Neuroprotection of photoreceptors by minocycline in light-induced retinal degeneration. Invest Ophthalmol Vis Sci 45(8): 2753-2759, 2004. (Pubitemid 38998874)
14. Popp RA, Congdon CC and Goodman JW: Spleen weight as a measure of marrow cell growth in irradiated mice. Proc Soc Exp Biol Med 120(2): 395-398, 1965.
15. Gale RP: Immediate medical consequences of nuclear accidents. Lessons from Chernobyl. JAMA 258(5): 625-628, 1987.
16. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC and Mitchell JB: Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 15(4): 360-371, 2010.
17. Baiocchi G, Scambia G, Benedetti P, Menichella G, Testa U, Pierelli L, Martucci R, Foddai ML, Bizzi B, Mancuso S and Peschle C: Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery. Cancer Res 53(6): 1297-1303, 1993. (Pubitemid 23097106)
18. Colotta F, Re F, Polentarutti N, Sozzani S and Mantovani A: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80(8): 2012-2020, 1992.
19. Cassatella MA: The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16(1): 21-26, 1995.
20. Cicco NA, Lindemann A, Content J, Vandenbussche P, Lubbert M, Gauss J, Mertelsmann R and Herrmann F: Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood 75(10): 2049-2052, 1990. (Pubitemid 20180296)
21. Luheshi NM, Rothwell NJ and Brough D: Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin- 1 therapy. Br J Pharmacol 157(8): 1318-1329, 2009.
22. Neta R: Modulation with cytokines of radiation injury: suggested mechanisms of action. Environ Health Perspect 105(Suppl 6): 1463-1465, 1997.
23. Sureda A, Valls A, Kadar E, Algara M, Ingles-Esteve J, Bigas A, Jaume M, Lacruz M, Tobajas LM, Rutllant M and Garcia J: A single dose of granulocyte colony-stimulating factor modifies radiation-induced death in B6D2F1 mice. Exp Hematol 21(12): 1605-1607, 1993. (Pubitemid 24216803)
24. Okano A, Suzuki C, Takatsuki F, Akiyama Y, Koike K, Ozawa K, Hirano T, Kishimoto T, Nakahata T and Asano S: In vitro expansion of the murine pluripotent hemopoietic stem cell population in response to interleukin 3 and interleukin 6. Application to bone marrow transplantation. Transplantation 48(3): 495-498, 1989. (Pubitemid 19236520)
25. Collins MK, Marvel J, Malde P and Lopez-Rivas A: Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA-damaging agents. J Exp Med 176(4): 1043-1051, 1992.
26. Owen WF, Jr., Rothenberg ME, Silberstein DS, Gasson JC, Stevens RL, Austen KF and Soberman RJ: Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med 166(1): 129-141, 1987. (Pubitemid 17101894)
27. Peterson VM, Adamovicz JJ, Elliott TB, Moore MM, Madonna GS, Jackson WE, 3rd, Ledney GD and Gause WC: Gene expression of hematoregulatory cytokines is elevated endogenously after sublethal gamma irradiation and is differentially enhanced by therapeutic administration of biologic response modifiers. J Immunol 153(5): 2321-2330, 1994. (Pubitemid 24256704)
28. Neta R, Sztein MB, Oppenheim JJ, Gillis S and Douches SD: The in vivo effects of interleukin 1. I. Bone marrow cells are induced to cycle after administration of interleukin 1. J Immunol 139(6): 1861-1866, 1987. (Pubitemid 17141615)
29. Eastgate J, Moreb J, Nick HS, Suzuki K, Taniguchi N and Zucali JR: A role for manganese superoxide dismutase in radioprotection of hematopoietic stem cells by interleukin-1. Blood 81(3): 639-646, 1993. (Pubitemid 23040854)
30. Borrelli A, Schiattarella A, Mancini R, Morrica B, Cerciello V, Mormile M, d'Alesio V, Bottalico L, Morelli F, D'Armiento M, D'Armiento FP and Mancini A: A recombinant MnSOD is radioprotective for normal cells and radiosensitizing for tumor cells. Free Radic Biol Med 46(1): 110-116, 2009.
31. Gershanovich ML, Filatova LV, Ketlinsky SA and Simbirtsev AS: Recombinant human interleukin-1 beta: new possibilities for the prophylaxis and correction of toxic myelodepression in patients with malignant tumors. II. Phase II study of the protective effect of recombinant human interleukin-1 beta on myelodepression induced by chemotherapy in cancer patients. Eur Cytokine Netw 12(4): 671-675, 2001. (Pubitemid 34062155)
32. Neta R, Douches S and Oppenheim JJ: Interleukin 1 is a radioprotector. J Immunol 136(7): 2483-2485, 1986. (Pubitemid 16136827)
33. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguschi T and Kishimoto T: Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324(6092): 73-76, 1986. (Pubitemid 16008419)
34. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H and Kohler G: Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362(6417): 245-248, 1993. (Pubitemid 23093629)
35. Peschel C, Paul WE, Ohara J and Green I: Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cells. Blood 70(1): 254-263, 1987. (Pubitemid 17111271)
36. Lampinen M, Carlson M, Hakansson LD and Venge P: Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 59(8): 793-805, 2004. (Pubitemid 39005818)
37. Diehl S and Rincon M: The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 39(9): 531-536, 2002. (Pubitemid 35341492)
38. Asadullah K, Sterry W and Volk HD: Interleukin-10 therapy - review of a new approach. Pharmacol Rev 55(2): 241-269, 2003. (Pubitemid 36666048)
39. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J and Lebecque S: T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183(6): 2593-2603, 1996. (Pubitemid 26193037)
40. + T cells display enhanced antitumor immunity. Blood 114(3): 596-599, 2009.
41. Geissler K, Kabrna E, Kollars M, Ohler L, Berer A, Burgmann H, Winkler S, Willheim M, Hinterberger W and Lechner K: Interleukin-10 inhibits in vitro hematopoietic suppression and production of interferon-gamma and tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with aplastic anemia. Hematol J 3(4): 206-213, 2002.
42. Lee SM, Yune TY, Kim SJ, Park DW, Lee YK, Kim YC, Oh YJ, Markelonis GJ and Oh TH: Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J Neurotrauma 20(10): 1017-1027, 2003. (Pubitemid 37288561)
43. Zhang LJ, Zheng WD, Chen YX, Huang YH, Chen ZX, Zhang SJ, Shi MN and Wang XZ: Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. Hepatogastroenterology 54(79): 2092-2098, 2007.
44. Nelson DR, Tu Z, Soldevila-Pico C, Abdelmalek M, Zhu H, Xu YL, Cabrera R, Liu C and Davis GL: Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology 38(4): 859-868, 2003.
45. McKenzie GJ, Emson CL, Bell SE, Anderson S, Fallon P, Zurawski G, Murray R, Grencis R and McKenzie AN: Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9(3): 423-432, 1998.
46. Hoshino T, Winkler-Pickett RT, Mason AT, Ortaldo JR and Young HA: IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. J Immunol 162(1): 51-59, 1999. (Pubitemid 29018903)
47. Bellinghausen I, Brand P, Bottcher I, Klostermann B, Knop J and Saloga J: Production of interleukin-13 by human dendritic cells after stimulation with protein allergens is a key factor for induction of T helper 2 cytokines and is associated with activation of signal transducer and activator of transcription-6. Immunology 108(2): 167-176, 2003. (Pubitemid 36232866)
48. Spencer LA, Szela CT, Perez SA, Kirchhoffer CL, Neves JS, Radke AL and Weller PF: Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J Leukoc Biol 85(1): 117-123, 2009.
49. Gessner A, Mohrs K and Mohrs M: Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J Immunol 174(2): 1063-1072, 2005. (Pubitemid 40094303)
50. Chen X, Ma X, Jiang Y, Pi R, Liu Y and Ma L: The prospects of minocycline in multiple sclerosis. J Neuroimmunol 235(1-2): 1-8, 2011.
51. Jacobsen SE, Okkenhaug C, Veiby OP, Caput D, Ferrara P and Minty A: Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J Exp Med 180(1): 75-82, 1994. (Pubitemid 24181057)
52. Walzer T, Marcais A, Saltel F, Bella C, Jurdic P and Marvel J: Cutting edge: immediate RANTES secretion by resting memory CD8 T cells following antigenic stimulation. J Immunol 170(4): 1615-1619, 2003. (Pubitemid 36197372)
53. + T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity 20(2): 219-230, 2004.
54. hi T cells to p53-dependent cell death results in persistence of immunologic memory after total-body irradiation. J Immunol 187(8): 4100-4108, 2011.
55. Zeng Y, Chen X, Larmonier N, Larmonier C, Li G, Sepassi M, Marron M, Andreansky S and Katsanis E: Natural killer cells play a key role in the antitumor immunity generated by chaperone-rich cell lysate vaccination. Int J Cancer 119(11): 2624-2631, 2006. (Pubitemid 44691318)
56. Alam R, Stafford S, Forsythe P, Harrison R, Faubion D, Lett-Brown MA and Grant JA: RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 150(8 Pt 1): 3442-3448, 1993.
57. Gao JL, Kuhns DB, Tiffany HL, McDermott D, Li X, Francke U and Murphy PM: Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor. J Exp Med 177(5): 1421-1427, 1993. (Pubitemid 23117132)
58. Makino Y, Cook DN, Smithies O, Hwang OY, Neilson EG, Turka LA, Sato H, Wells AD and Danoff TM: Impaired T cell function in RANTES-deficient mice. Clin Immunol 102(3): 302-309, 2002. (Pubitemid 34259264)
59. Crawford A, Angelosanto JM, Nadwodny KL, Blackburn SD and Wherry EJ: A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection. PLoS Pathog 7(7): e1002098, 2011.
60. Kloppenburg M, Verweij CL, Miltenburg AM, Verhoeven AJ, Daha MR, Dijkmans BA and Breedveld FC: The influence of tetracyclines on T cell activation. Clin Exp Immunol 102(3): 635-641, 1995. (Pubitemid 26013229)
61. Eng VM, Car BD, Schnyder B, Lorenz M, Lugli S, Aguet M, Anderson TD, Ryffel B and Quesniaux VF: The stimulatory effects of interleukin (IL)-12 on hematopoiesis are antagonized by IL-12-induced interferon gamma in vivo. J Exp Med 181(5): 1893-1898, 1995.
62. Peetre C, Gullberg U, Nilsson E and Olsson I: Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor. J Clin Invest 78(6): 1694-1700, 1986. (Pubitemid 17219535)
63. Murase T, Hotta T, Saito H and Ohno R: Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells. Blood 69(2): 467-472, 1987. (Pubitemid 17022015)
64. Navas TA, Mohindru M, Estes M, Ma JY, Sokol L, Pahanish P, Parmar S, Haghnazari E, Zhou L, Collins R, Kerr I, Nguyen AN, Xu Y, Platanias LC, List AA, Higgins LS and Verma A: Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors. Blood 108(13): 4170-4177, 2006. (Pubitemid 44913289)
65. Tikka T, Fiebich BL, Goldsteins G, Keinanen R and Koistinaho J: Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21(8): 2580-2588, 2001. (Pubitemid 32298200)
66. Nakamura K, Williams IR and Kupper TS: Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J Invest Dermatol 105(5): 635-643, 1995.
67. Moore MA: Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 78(1): 1-19, 1991.
68. Karpus WJ and Kennedy KJ: MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis, as well as Th1/Th2 lymphocyte differentiation. J Leukoc Biol 62(5): 681-687, 1997. (Pubitemid 27519780)
69. Ao X, Zhao L, Davis MA, Lubman DM, Lawrence TS and Kong FM: Radiation produces differential changes in cytokine profiles in radiation lung fibrosis sensitive and resistant mice. J Hematol Oncol 2: 6, 2009.
70. Cassatella MA, Gasperini S, Calzetti F, Bertagnin A, Luster AD and McDonald PP: Regulated production of the interferon-gamma-inducible protein-10 (IP-10) chemokine by human neutrophils. Eur J Immunol 27(1): 111-115, 1997. (Pubitemid 27046066)
71. Sarris AH, Broxmeyer HE, Wirthmueller U, Karasavvas N, Cooper S, Lu L, Krueger J and Ravetch JV: Human interferon-inducible protein 10: expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors. J Exp Med 178(3): 1127-1132, 1993. (Pubitemid 23260454)
72. Aronica SM, Mantel C, Gonin R, Marshall MS, Sarris A, Cooper S, Hague N, Zhang XF and Broxmeyer HE: Interferon-inducible protein 10 and macrophage inflammatory protein-1 alpha inhibit growth factor stimulation of RAF-1 kinase activity and protein synthesis in a human growth factor-dependent hematopoietic cell line. J Biol Chem 270(37): 21998-22007, 1995.
73. Keane MP, Arenberg DA, Lynch JP, 3rd, Whyte RI, Iannettoni MD, Burdick MD, Wilke CA, Morris SB, Glass MC, DiGiovine B, Kunkel SL and Strieter RM: The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 159(3): 1437-1443, 1997.
74. van Roon JA, Glaudemans KA, Bijlsma JW and Lafeber FP: Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis. Ann Rheum Dis 62(2): 113-119, 2003. (Pubitemid 36135385)
75. Akashi K, Kondo M and Weissman IL: Role of interleukin-7 in T-cell development from hematopoietic stem cells. Immunol Rev 165: 13-28, 1998. (Pubitemid 28524199)
76. + T-regulatory cells. J Immunother 29(3): 313-319, 2006.
77. Zamarron BF and Chen W: Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci 7(5): 651-658, 2011.
78. Mougiakakos D, Johansson CC, Jitschin R, Bottcher M and Kiessling R: Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress. Blood 117(3): 857-861, 2011.
79. Or R, Abdul-Hai A and Ben-Yehuda A: Reviewing the potential utility of interleukin-7 as a promoter of thymopoiesis and immune recovery. Cytokines Cell Mol Ther 4(4): 287-294, 1998. (Pubitemid 28543011)
80. Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G, Enk A, Steinman RM, Romani N and Schuler G: Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 26(3): 659-668, 1996. (Pubitemid 26091397)
81. Golab J, Stoklosa T, Zagozdzon R, Kaca A, Giermasz A, Pojda Z, Machaj E, Dabrowska A, Feleszko W, Lasek W, Iwan-Osiecka A and Jakobisiak M: G-CSF prevents the suppression of bone marrow hematopoiesis induced by IL-12 and augments its antitumor activity in a melanoma model in mice. Ann Oncol 9(1): 63-69, 1998. (Pubitemid 28125766)
82. Robertson MJ and Ritz J: Interleukin-12: basic biology and potential applications in cancer treatment. Oncologist 1(1 & 2): 88-97, 1996. (Pubitemid 126669376)
83. Duffy AM, Bouchier-Hayes DJ and Harmey JH: Vascular Endothelial Growth Factor (VEGF) and Its Role in Non-Endothelial Cells: Autocrine Signalling by VEGF, Landes Bioscience: TX, 2012.
84. Helotera H and Alitalo K: The VEGF family, the inside story. Cell 130(4): 591-592, 2007. (Pubitemid 47268069)
85. Park JS, Qiao L, Su ZZ, Hinman D, Willoughby K, McKinstry R, Yacoub A, Duigou GJ, Young CS, Grant S, Hagan MP, Ellis E, Fisher PB and Dent P: Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways. Oncogene 20(25): 3266-3280, 2001. (Pubitemid 32553679)
86. Giuliani F, Hader W and Yong VW: Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction. J Leukoc Biol 78(1): 135-143, 2005. (Pubitemid 40979952)
87. Mattei F, Schiavoni G, Belardelli F and Tough DF: IL-15 is expressed by dendritic cells in response to type I IFN, doublestranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol 167(3): 1179-1187, 2001. (Pubitemid 32703111)
88. Venkataraman M and Westerman MP: Radiation causes increased production and decreased utilization of IL-2 in human mononuclear cells. Cytokine 2(1): 35-44, 1990.
89. Hoyer KK, Dooms H, Barron L and Abbas AK: Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 226: 19-28, 2008.